Identificación de la relación Entre Componentes de la Inmunidad Celular y Factores Inflamatorios y neuroendócrinos Como Determinantes Del pronóstico clínico en el síndrome Coronario Agudo

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

In acute coronary syndrome (ACS), there is an increase in cortisol levels, as an expression of the stress response, and C-reactive protein, as an expression of the inflammatory response, which are in turn associated with changes in the components of cellular immunity, and ultimately are predictors of clinical events. The objective of this study is to demonstrate that, within the frame of reference of ACS, beyond the thrombotic phenomenon that leads to ischemia and myocardial necrosis, there is an activation of an inflammatory and stress response, evidenced by an elevation of CRP and cortisol, respectively, and sequentially modifications in the components of cellular immunity in peripheral blood that convey prognostic value during hospitalization and after discharge. A prospective, observational, analytical, unicentric study of consecutive patients with ACS, with telephone follow-up to 6 months, will be carried out. For 2 years, all eligible patients admitted with a diagnosis of ACS to the Coronary Care Unit of the Hospital de Clínicas José de San Martín in Buenos Aires will be registered consecutively.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 21
View:

• Are over 21 years of age and admitted to the Coronary Unit of the Hospital de Clínicas with a diagnosis of Acute Coronary Syndrome (ACS).

• Agree to participate in the study through informed consent.

Locations
Other Locations
Argentina
Hospital de Clinicas Jose de San Martin
RECRUITING
Buenos Aires
Contact Information
Primary
Diego Costa, MD, MSc.
diegosta@gmail.com
54 9 11 6198 4472
Backup
Sandra P Sweiszkowski, MD, MSc.
sandraswies@gmail.com
54 9 11 5053 3633
Time Frame
Start Date: 2024-01-01
Estimated Completion Date: 2026-07-01
Participants
Target number of participants: 150
Related Therapeutic Areas
Sponsors
Leads: Hospital de Clinicas José de San Martín
Collaborators: University of Buenos Aires

This content was sourced from clinicaltrials.gov